Comments
Pharma major Dr Reddy’s Laboratories has voluntarily recalled its hypertension drug, Metoprolol Succinate extended release tablets, from the US market.
According to a notification of the US Food and Drug Administration on its Website, the recall was classified as Class II and was due to failure in a dissolution test last month.
Over 13,000 bottles of the drug were being recalled. When contacted, Dr Reddy’s spokesperson told BusinessLine that it was a voluntary recall with ‘negligible’ financial implications.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.